{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T16:45:20Z","timestamp":1758818720435,"version":"3.37.3"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2024,6,15]],"date-time":"2024-06-15T00:00:00Z","timestamp":1718409600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,6,15]],"date-time":"2024-06-15T00:00:00Z","timestamp":1718409600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"crossref","award":["333202216"],"award-info":[{"award-number":["333202216"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Beijing Natural Science Haidian Frontier Foundation","award":["L222081"],"award-info":[{"award-number":["L222081"]}]},{"name":"National High Level Hospital Clinical Research Funding","award":["2022-PUMCH-A-193"],"award-info":[{"award-number":["2022-PUMCH-A-193"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1007\/s00277-024-05842-5","type":"journal-article","created":{"date-parts":[[2024,6,15]],"date-time":"2024-06-15T19:01:37Z","timestamp":1718478097000},"page":"3229-3233","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Co-occurrence of Erdheim-Chester disease and clonally evolving acute myeloid leukemia with FLT3-ITD and PTPN11 mutations"],"prefix":"10.1007","volume":"103","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9424-6540","authenticated-orcid":false,"given":"Xue-zhu","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8032-060X","authenticated-orcid":false,"given":"Xue-min","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun-mei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2153-9470","authenticated-orcid":false,"given":"Hao","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4549-0694","authenticated-orcid":false,"given":"Jian","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7884-3073","authenticated-orcid":false,"given":"Xin-xin","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,6,15]]},"reference":[{"issue":"2","key":"5842_CR1","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1182\/blood-2016-12-757823","volume":"130","author":"P Milne","year":"2017","unstructured":"Milne P, Bigley V, Bacon CM, N\u00e9el A, McGovern N, Bomken S et al (2017) Hematopoietic origin of Langerhans cell histiocytosis and Erdheim-Chester disease in adults. Blood 130(2):167\u2013175","journal-title":"Blood"},{"issue":"14","key":"5842_CR2","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1182\/blood-2017-01-765107","volume":"130","author":"BH Durham","year":"2017","unstructured":"Durham BH, Getta B, Dietrich S, Taylor J, Won H, Bogenberger JM et al (2017) Genomic analysis of hairy cell leukemia identifies novel recurrent genetic alterations. Blood 130(14):1644\u20131648","journal-title":"Blood"},{"issue":"8","key":"5842_CR3","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1182\/blood-2017-01-761718","volume":"130","author":"M Papo","year":"2017","unstructured":"Papo M, Diamond EL, Cohen-Aubart F, Emile JF, Roos-Weil D, Gupta N et al (2017) High prevalence of myeloid neoplasms in adults with non\u2013Langerhans cell histiocytosis. Blood 130(8):1007\u20131013","journal-title":"Blood"},{"issue":"2","key":"5842_CR4","doi-asserted-by":"publisher","first-page":"e51","DOI":"10.1111\/bjh.16177","volume":"187","author":"G Goyal","year":"2019","unstructured":"Goyal G, Liu Y, Ravindran A, Al-Kali A, Go RS, Patnaik MM et al (2019) Concomitant Erdheim-Chester disease and chronic myelomonocytic leukaemia: genomic insights into a common clonal origin. Br J Haematol 187(2):e51\u2013e54","journal-title":"Br J Haematol"},{"issue":"11","key":"5842_CR5","doi-asserted-by":"publisher","first-page":"e530","DOI":"10.3324\/haematol.2019.223552","volume":"104","author":"P Bonnet","year":"2019","unstructured":"Bonnet P, Chasset F, Moguelet P, Abisror N, Itzykson R, Bouaziz JD et al (2019) Erdheim-Chester disease associated with chronic myelomonocytic leukemia harboring the same clonal mutation. Haematologica 104(11):e530\u2013e533","journal-title":"Haematologica"},{"issue":"2","key":"5842_CR6","doi-asserted-by":"publisher","first-page":"e84","DOI":"10.3324\/haematol.2019.234187","volume":"105","author":"G Goyal","year":"2020","unstructured":"Goyal G, Ravindran A, Liu Y, He R, Shah MV, Bennani NN et al (2020) Bone marrow findings in Erdheim-Chester disease: increased prevalence of chronic myeloid neoplasms. Haematologica 105(2):e84\u2013e86","journal-title":"Haematologica"},{"issue":"8","key":"5842_CR7","doi-asserted-by":"publisher","first-page":"e373","DOI":"10.3324\/haematol.2019.217794","volume":"104","author":"A Ghobadi","year":"2019","unstructured":"Ghobadi A, Miller CA, Li T, O\u2019Laughlin M, Lee YS, Ali M et al (2019) Shared cell of origin in a patient with Erdheim-Chester disease and acute myeloid leukemia. Haematologica 104(8):e373\u2013e375","journal-title":"Haematologica"},{"key":"5842_CR8","doi-asserted-by":"publisher","first-page":"11689","DOI":"10.2147\/OTT.S276497","volume":"13","author":"SG Papageorgiou","year":"2020","unstructured":"Papageorgiou SG, Divane A, Roumelioti M, Kottaridi C, Bouchla A, Georgakopoulos A et al (2020) Erdheim-Chester Disease and Acute Myeloid Leukemia with Mutated NPM1 in a Patient with Clonal Hematopoiesis: A Case Report. OncoTargets Ther 13:11689\u201311695","journal-title":"OncoTargets Ther"},{"issue":"1","key":"5842_CR9","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1002\/cjp2.177","volume":"7","author":"PG Kemps","year":"2021","unstructured":"Kemps PG, Hebeda KM, Pals ST, Verdijk RM, Lam KH, Bruggink AH et al (2021) Spectrum of histiocytic neoplasms associated with diverse haematological malignancies bearing the same oncogenic mutation. J Pathol Clin Res 7(1):10\u201326","journal-title":"J Pathol Clin Res"},{"key":"5842_CR10","doi-asserted-by":"publisher","first-page":"151928","DOI":"10.1016\/j.anndiagpath.2022.151928","volume":"58","author":"G Sotolongo","year":"2022","unstructured":"Sotolongo G, Zhao Y, McCall C, Wang E (2022) Erdheim-Chester disease collides with myelodysplastic neoplasm in bone marrow. Ann Diagn Pathol 58:151928","journal-title":"Ann Diagn Pathol"},{"issue":"22","key":"5842_CR11","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1182\/blood.2019003507","volume":"135","author":"G Goyal","year":"2020","unstructured":"Goyal G, Heaney ML, Collin M, Cohen-Aubart F, Vaglio A, Durham BH et al (2020) Erdheim-Chester disease: consensus recommendations for evaluation, diagnosis, and treatment in the molecular era. Blood 135(22):1929\u20131945","journal-title":"Blood"},{"issue":"7","key":"5842_CR12","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1007\/s11912-019-0810-6","volume":"21","author":"M Papo","year":"2019","unstructured":"Papo M, Cohen-Aubart F, Trefond L, Bauvois A, Amoura Z, Emile JF et al (2019) Systemic Histiocytosis (Langerhans Cell Histiocytosis, Erdheim-Chester Disease, Destombes\u2013Rosai\u2013Dorfman Disease): from Oncogenic Mutations to Inflammatory Disorders. Curr Oncol Rep 21(7):62","journal-title":"Curr Oncol Rep"},{"issue":"3","key":"5842_CR13","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1002\/ajh.26822","volume":"98","author":"S Shimony","year":"2023","unstructured":"Shimony S, Stahl M, Stone RM (2023) Acute myeloid leukemia: 2023 update on diagnosis, risk-stratification, and management. Am J Hematol 98(3):502\u2013526","journal-title":"Am J Hematol"},{"issue":"6","key":"5842_CR14","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1016\/j.cell.2019.01.031","volume":"176","author":"P Van Galen","year":"2019","unstructured":"Van Galen P, Hovestadt V, Wadsworth Ii MH, Hughes TK, Griffin GK, Battaglia S et al (2019) Single-Cell RNA-Seq Reveals AML Hierarchies Relevant to Disease Progression and Immunity. Cell 176(6):1265-1281.e24","journal-title":"Cell"},{"issue":"10","key":"5842_CR15","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.1038\/s41375-023-01994-x","volume":"37","author":"J Othman","year":"2023","unstructured":"Othman J, Potter N, Mokretar K, Taussig D, Khan A, Krishnamurthy P et al (2023) FLT3 inhibitors as MRD-guided salvage treatment for molecular failure in FLT3 mutated AML. Leukemia 37(10):2066\u20132072","journal-title":"Leukemia"},{"issue":"8","key":"5842_CR16","doi-asserted-by":"publisher","first-page":"2312","DOI":"10.3390\/cancers15082312","volume":"15","author":"K Fedorov","year":"2023","unstructured":"Fedorov K, Maiti A, Konopleva M (2023) Targeting FLT3 Mutation in Acute Myeloid Leukemia: Current Strategies and Future Directions. Cancers 15(8):2312","journal-title":"Cancers"},{"issue":"17","key":"5842_CR17","doi-asserted-by":"publisher","first-page":"3279","DOI":"10.1182\/bloodadvances.2021004631","volume":"5","author":"S Stasik","year":"2021","unstructured":"Stasik S (2021) Impact of PTPN11 mutations on clinical outcome analyzed in 1529 patients with acute myeloid leukemia. Blood Adv 5(17):3279\u20133289","journal-title":"Blood Adv"},{"issue":"42","key":"5842_CR18","doi-asserted-by":"publisher","first-page":"26340","DOI":"10.1073\/pnas.2014732117","volume":"117","author":"M Bill","year":"2020","unstructured":"Bill M, Mr\u00f3zek K, Kohlschmidt J, Eisfeld AK, Walker CJ, Nicolet D et al (2020) Mutational landscape and clinical outcome of patients with de novo acute myeloid leukemia and rearrangements involving 11q23\/ KMT2A. Proc Natl Acad Sci 117(42):26340\u201326346","journal-title":"Proc Natl Acad Sci"},{"issue":"3","key":"5842_CR19","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1038\/s41375-020-0920-z","volume":"35","author":"M Alfayez","year":"2021","unstructured":"Alfayez M (2021) The Clinical impact of PTPN11 mutations in adults with acute myeloid leukemia. Leukemia 35(3):691\u2013700","journal-title":"Leukemia"},{"issue":"18","key":"5842_CR20","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1182\/blood.2023021212","volume":"142","author":"AA Acosta-Medina","year":"2023","unstructured":"Acosta-Medina AA, Kemps PG, Zondag TCE, Abeykoon JP, Forma-Borst J, Steenwijk EC et al (2023) BRAF V600E is associated with higher incidence of second cancers in adults with Langerhans cell histiocytosis. Blood 142(18):1570\u20131575","journal-title":"Blood"},{"issue":"4","key":"5842_CR21","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1182\/blood.2020005101","volume":"137","author":"F Cohen Aubart","year":"2021","unstructured":"Cohen Aubart F, Roos-Weil D, Armand M, Marceau-Renaut A, Emile JF, Duployez N et al (2021) High frequency of clonal hematopoiesis in Erdheim-Chester disease. Blood 137(4):485\u2013492","journal-title":"Blood"},{"key":"5842_CR22","doi-asserted-by":"crossref","unstructured":"Grissa D, Junge A, Oprea TI, Jensen LJ. 2022 DISEASES 2.0: a weekly updated database of disease\u2013gene associations from text mining and data integration. Database Oxf baac019","DOI":"10.1093\/database\/baac019"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-024-05842-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-024-05842-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-024-05842-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,27]],"date-time":"2024-07-27T06:09:22Z","timestamp":1722060562000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-024-05842-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,15]]},"references-count":22,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["5842"],"URL":"https:\/\/doi.org\/10.1007\/s00277-024-05842-5","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"type":"print","value":"0939-5555"},{"type":"electronic","value":"1432-0584"}],"subject":[],"published":{"date-parts":[[2024,6,15]]},"assertion":[{"value":"20 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as potential conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}},{"value":"This study has been approved by the Ethics Committee and the Institutional Review Board of the Peking Union Medical Hospital.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient consent statement"}}]}}